Lineage Cell Therapeutics Inc (LCTX) Annual Income Statement (USD)
LCTX Quarterly Financials (USD)
Frequently Asked Questions About Lineage Cell Therapeutics Inc (LCTX) Stock
Lineage Cell Therapeutics Inc's (LCTX) last reported annual revenue was USD 8.95 Million.
Lineage Cell Therapeutics Inc's (LCTX) annual revenue growth rate based on the revenue reported in the past 5 years is : 44.58%
Lineage Cell Therapeutics Inc's(LCTX) is not profitable as of its last reported annual financials.
The net profit margin for Lineage Cell Therapeutics Inc's(LCTX) from its laster reported year is -240.20%
The return on equity (ROE) for Lineage Cell Therapeutics Inc's(LCTX) from its last reported annual financials is : -32.07%
The return on assets (ROA) for Lineage Cell Therapeutics Inc's(LCTX) from its last reported annual financials is : -11.80%
The return on invested capital (ROIC) for Lineage Cell Therapeutics Inc's(LCTX) from its last reported annual financials is : -33.53%
The Debt to Equity ratio for Lineage Cell Therapeutics Inc's(LCTX) from its last reported annual financials is : 0.00%
The dividend yield for Lineage Cell Therapeutics Inc's(LCTX) from its laster reported year is 0.00%
Lineage Cell Therapeutics Inc's(LCTX) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LCTX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
